The current study therefore serves to extend these results and look further into the effects of downregulating LRP/LR on cancer hallmarks in A549 lung cancer cells, as we have previously shown they exhibit increased LRP/LR levels compared with non‐tumourigenic cells [17, 21]. The gene discussed is RPSA; the disease is lung cancer.